Changeflow GovPing Healthcare & Life Sciences Production Method for Retinal Tissue, EP3868873...
Routine Notice Added Final

Production Method for Retinal Tissue, EP3868873A1, Apr 15

Favicon for changeflow.com EPO Patent Bulletin - Biotech (C12N)
Published
Detected
Email

Summary

The European Patent Office published patent EP3868873A1 titled 'Production Method for Retinal Tissue' on April 15, 2026. The patent names RACTHERA Co., Ltd. and RIKEN as applicants, with inventors including KUWAHARA, Atsushi, YAMASAKI, Suguru, HIRAMINE, Yasushi, SASAI, Yoshiki, and TAKAHASHI, Masayo. IPC classifications include C12N 5/079 (cell or tissue culture), A61K 35/44 (eye-related preparations), A61L 27/00 (prosthetic implants), and A61P 27/02 (ophthalmic agents).

Published by EPO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors EPO Patent Bulletin - Biotech (C12N) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 61 changes logged to date.

What changed

The EPO Patent Bulletin published patent application EP3868873A1, a production method for retinal tissue, on April 15, 2026. The patent is classified under multiple IPC codes related to cell culture, ophthalmic preparations, and prosthetic materials.

For entities engaged in biotechnology, pharmaceutical research, or medical device development involving ophthalmic applications, this patent establishes intellectual property protection for retinal tissue production methods in designated EPO member states. RACTHERA Co., Ltd. and RIKEN now hold exclusive rights to practice the claimed methods within the designated territories.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← EPO Patent Bulletin

PRODUCTION METHOD FOR RETINAL TISSUE

Publication EP3868873A1 Kind: A1 Apr 15, 2026

Applicants

RACTHERA Co., Ltd., RIKEN

Inventors

KUWAHARA, Atsushi, YAMASAKI, Suguru, HIRAMINE, Yasushi, SASAI, Yoshiki, TAKAHASHI, Masayo

IPC Classifications

C12N 5/079 20100101AFI20210713BHEP A61K 35/44 20150101ALI20210713BHEP A61L 27/00 20060101ALI20210713BHEP A61P 27/02 20060101ALI20210713BHEP C12N 5/10 20060101ALI20210713BHEP C12Q 1/02 20060101ALI20210713BHEP G01N 33/50 20060101ALI20210713BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get daily alerts for EPO Patent Bulletin - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from EPO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
EPO
Published
April 15th, 2026
Instrument
Notice
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Pharmaceutical companies Medical device makers Biotechnology firms
Industry sector
3254.1 Biotechnology
Activity scope
Patent examination IP licensing Biotech research
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Healthcare Medical Devices Biotechnology

Get alerts for this source

We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!